Stockscreener 앱 받기
1.45
3.57%
0.05
전일 마감가:
$1.40
열려 있는:
$1.3899
하루 거래량:
18,458
Relative Volume:
0.20
시가총액:
$4.25M
수익:
$5.31M
순이익/손실:
$-2.90M
주가수익비율:
-0.9761
EPS:
-1.4855
순현금흐름:
$-1.18M
1주 성능:
-1.36%
1개월 성능:
-11.59%
6개월 성능:
-36.40%
1년 성능:
-67.12%
1일 변동 폭
$1.341
$1.525
1주일 범위
$1.341
$1.525
52주 변동 폭
$1.07
$6.10
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.35 | 2.28B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.25 | 773.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.35 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.43 | 220.96M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.20 | 197.39M | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
11 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
Jook Yuen Low Net Worth (2026) - GuruFocus
Set Fui Chong Net Worth (2026) - GuruFocus
Fidelion Diagnostics Pte. Ltd. Net Worth (2026) - GuruFocus
Bin Abdul Hamid Muhammad Azrul Net Worth (2026) - GuruFocus
BioNexus Gene Lab Revenue Collapses 97% in Q2 as Major Customer Lost - Minichart
BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake - Stock Titan
BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share fully vested award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) CFO receives 96,774-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Stock News Today - TradingKey
BioNexus Gene Lab (BGLC) Surges 8.3% to $1.43: Can Momentum Break the $1.50 Ceiling?Volume Climax - dars.gov.et
BioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock Titan
BioNexus Gene Lab (BGLC) director files Form 3 with zero shares - stocktitan.net
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.613|Chg%:-0.027 - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher with Micro-Advance, Testing Key Resistance ZoneWedge Breakout - dars.gov.et
BioNexus Gene Lab Corp (BGLC) Faces Selling Pressure as Shares Slip 2.35%Sign of Strength - vinanet.vn
BioNexus Gene Lab (BGLC) Declines 2.35% – Support at $1.58 in FocusDollar Neutral Pair - Vinanet
12 Industrials Stocks Moving In Thursday's Pre-Market SessionEos Energy Enterprises, Inc.Right (NAS - Benzinga
Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Test Key ResistanceMoney Flow Index - dars.gov.et
Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Company Profile & Introduction - Moomoo
Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
자본화:
|
볼륨(24시간):